Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease
More to come with myositis in the offing
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 1, 2020
- Accepted in final form May 4, 2020
- First Published June 9, 2020.
Author Disclosures
- Marinos C. Dalakas, MD
- Marinos C. Dalakas, MD
Serves on the CIDP DSMB for Baxalta and Octapharma
NONE
Merck/Serono, OCTAPHARMA, PFIZER AG,
1. Neurology, editorial board (5 years, not compensated); 2)BMC Neurology (Section Editor, 5 years not compensated); 3) Acta Myologica, editorial board (5 years, not compensated); 5)Acta Neurologica Scandinavica editorial board ( 5 years, not compensated); 6)Therapeutic Advances in Neurology (Associate Editor; 4 years, compensated); 7) Annals of Neurology (3 years not compensated); 8) Neurology, Neuroimmunology Neuroinflammation (associate Editor); 9)Neurodiem (Associate editor)
NONE
NONE
NONE
Therapath, Baxter, Octapharma, Dysimmune Diseases Foundation
NONE
NONE
NONE
Received Institutional support to Thomas Jefferson University Neurology department or to Neuroimmunology Unit, University of Athens Medical School for research and education from: Merck-Serono, Genzyme, Novartis, Guillain-Barre/CIDP Foundation, Dysimmune diseases Foundation, InfuCare, and Newfactor
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology, Thomas Jefferson University, Philadelphia, PA, and the Neuroimmunology Unit, National and Kapodistrian University of Athens Medical School, Greece.
- Correspondence
Dr. Dalakas marinos.dalakas{at}jefferson.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Glossary
- GBS in the COVID-19 pandemic
- Significance of anosmia/ageusia and other cranial nerve palsies
- Autoimmunity of COVID-19–GBS: significance of sialic acids present in the coronaviruses and peripheral nerve myelin
- What is more to come with myositis in the offing
- Other emerging postinfectious autoimmune neurologic disorders
- Residual neurologic deficits in COVID-19–recovered patients: need for a systematic study
- Patients with autoimmune neurologic diseases: how is COVID-19 changing ongoing immunotherapies and the role of complement
- Study funding
- Disclosure
- Footnotes
- References
- Info & Disclosures
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Editor's Corner
N2 year in reviewJosep Dalmau, Marinos C. Dalakas, Dennis L. Kolson et al.Neurology: Neuroimmunology & Neuroinflammation, December 18, 2020 -
Editorial
Cranial neuropathies and COVID-19Neurotropism and autoimmunityFiona Costello, Marinos C. Dalakas et al.Neurology, June 02, 2020 -
Article
Miller Fisher syndrome and polyneuritis cranialis in COVID-19Consuelo Gutiérrez-Ortiz, Antonio Méndez-Guerrero, Sara Rodrigo-Rey et al.Neurology, April 17, 2020 -
Resident & Fellow Section
Clinical Reasoning: A case of COVID-19–associated pharyngeal-cervical-brachial variant of Guillain-Barré syndromeGiuseppe Liberatore, Tiziana De Santis, Pietro Emiliano Doneddu et al.Neurology, September 11, 2020